“showed a trend”

Met allele carriers showed a trend towards better performance in Raven's SPM compared to Val/Val carriers ( T 23 = 1.94, P = .065).

In the skeleton photoperiod group, turning the lights on did not significantly alter FAA ratios (F (4,24) = 0.78, p = .55), although premeal (ZT4-6) activity counts showed a trend to be lower on both light exposure days (F (4,24) = 2.54, p = .065).

Furthermore, 3D technique versus IMRT showed a trend toward worse local control for 3D ( p =0.065).

A repeated measures ANOVA of discriminability scores showed a trend toward a significant main effect of block ( F (2,44) = 2.914, p = 0.065), with discriminability tending to be lower in block 1 (0.631±0.116) than blocks 2 (0.795±0.367, p = 0.057) or 3 (0.705±0.236, p = 0.082).

CytB expression also showed a trend toward increased expression ( p = 0.065), but only in 6wkHFC mice, while no change in Cox1 expression was observed at either time point ( Figures 8C , D , F , G ).

Animals trained during the active phase of the light cycle showed a trend toward committing more reference memory errors than animals trained during the inactive phase ( F 1,22 = 3.8, p < 0.065); this effect interacted with day of training ( F 4,88 = 3.0, p < 0.03) such that the difference between active vs. inactive phase trained animals diminished over training ( p < 0.02 on first day of training; comparisons on other days not significant, Figure 6 A).

Ala carriers compared with Pro/Pro homozygotes showed a trend with lower incidence of microalbuminuria even after adjusting for sex, smoking status, and baseline A1C (HR 0.48 [95% CI 0.22–1.05]; P = 0.065), but not after adjusting also for baseline albuminuria (HR 0.64 [0.29–1.40]; P = 0.263).

Although non-significant, six out of seven samples showed a trend toward higher endogenous content after bleach + predigestion (t = −1.75, DF = 6, p value = 0.065).

No significant difference was observed in the number of retrieved oocytes between the two cycles; however, the number of blastocysts showed a trend toward being higher in the PPOS cycle compared to the GnRH antagonist cycle (p=0.065) (Table 2 ).

High MYC expression showed a trend toward worse survival (HR 2.60, 95% CI 0.94–7.15, p = 0.065).

Compared with wakefulness, response magnitude in spiking activity was moderately attenuated (gain of −17.25%, P = 0.022), and MI showed a trend for slight attenuation (gain = −12.1%, P = 0.065).

Although changes in dental status showed a trend towards a decline ( p = 0.065), these changes did not reach statistical significance.

Notably, ALS patients showed a trend toward increased assortativity in resting-state fMRI ( p = 0.065), possibly reflecting altered hub organization. 3.8.

Hepatic αKlotho expression showed a trend towards higher levels in LSL than in LB hens (P = 0.065; Fig. 2 A) with a significant difference in the MI0 group (P = 0.024; Fig. 2 A), while tibial (P < 0.001; Fig. 2 B) and renal (P < 0.001; Fig. 2 C) αKlotho expression were significantly higher in LB hens than in LSL hens.

Specifically, cutaneous melanoma patients who responded to immune checkpoint therapy showed a trend toward lower levels of baseline serum PGJ 2 than mucosal responders ( p = 0.065) ( Figure 3 e).

Postoperative margin positivity showed a trend favoring the robotic group (4.9% vs. 14.8%, p = 0.065 post-match); however, the difference was not statistically significant.

The analysis of the interaction between intervention groups and stroke type showed a trend toward interaction only between the Welwalk and cerebral infarction groups for both the FAS and PPS, respectively (HR 4.167 [95%CI 0.914–18.995], p = 0.065, HR 4.443 [95%CI 0.973–20.279], p = 0.054).

For the SSR trials, the effect of Group was significant on PC2 (p < 0.001) and showed a trend on PC1 (p = 0.065).

Bilateral BA45 volume also showed a trend with DDK rate (left = 0.638, P = 0.065; right = 0.645, P = 0.061).

In COPD ( Figure 2A ), monocyte-lineage fractions were significantly higher (p = 0.008), lymphocytes were lower (p = 0.007), and neutrophils showed a trend toward increase (p = 0.065).

In addition, completion of chemotherapy as planned showed a trend for better loco-regional control ( p = 0.065).

Sensorimotor STN overlap was not directly linked to LEDD reduction but was positively associated with motor improvement (β=0.34, p=0.001), which showed a trend-level effect on LEDD reduction (β=0.16, p=0.065).

Following MCAO, TLR4 flox/flox ; Vil Cre mice exhibited significantly reduced brain infarction ratios, whereas TLR4 flox/flox ; Emx1 Cre mice showed a trend toward reduction in brain infarction ratios ( P = 0.065), compared with WT mice (Fig. 3 C).

Leucine/isoleucine was also significantly higher in the cardiometabolic group compared to the early-mild group ( p < 0.0001) and showed a trend toward statistical significance compared to the inflammatory-fibrotic group ( p = 0.065) (Fig.

6 J, P < 0.05, one-way ANOVA with Tukey's post-hoc test), while the Ce group showed a trend towards higher expression ( Fig. 6 J, P = 0.065, one-way ANOVA with Tukey's post-hoc test).